Differences between a patient’s true normal range and the population-based reference interval can create problems for doctors ...

Adding genetic testing to the evaluation of pediatric patients with neurodevelopmental disorders (NDD) resulted in more ...

Genetic testing, which has expanded in recent years with advances in technology and the development of consumer products, is ...

The test used two synovial fluid biomarkers to accurately differentiate osteoarthritis from inflammatory arthritis, but its ...

GP practices are facing confusion over different approaches to asthma diagnosis set out in the QOF and in the new UK joint ...

The engagement with an EU-based GMP manufacturing facility enables timely production and preparation for clinical trial. The EU-based GMP ...

Broad enrollment criteria appear to have scuttled the trial, which was designed to test whether ctDNA could identify patients ...

Roche launches its cobas® Mass Spec solution, bringing mass spectrometry to the routine clinical lab Clinical mass ...

The global in vitro diagnostics (IVD) market has exhibited significant growth, with its valuation rising from $67,111 million in 2019 to an estimated $91,093 million by 2027. This ...

Milestone demonstrates the growing customer adoption of the Company’s proprietary technologyLEXINGTON, Mass., Dec. 17, 2024 ...

The global artificial intelligence in clinical trials market is forecasted to grow steadily from US$1.20 billion in 2023 to ...

Despite these limitations, the researchers believe the study highlights the underutilization of Lp (a) testing in US individuals with ASCVD, despite the strong association between elevated Lp (a) ...